Earnings Recaps

Browse reported earnings of the most popular stocks

Nov 13, 2026 Nov 12, 2026 Nov 11, 2026 Nov 10, 2026 Nov 9, 2026 Nov 8, 2026 Nov 7, 2026 Nov 6, 2026 Nov 5, 2026 Nov 4, 2026 Nov 3, 2026 Nov 2, 2026 Nov 1, 2026 Oct 31, 2026 Oct 30, 2026 Oct 29, 2026 Oct 28, 2026 Oct 27, 2026 Oct 26, 2026 Oct 25, 2026 Oct 24, 2026 Oct 23, 2026 Oct 22, 2026 Oct 21, 2026 Oct 20, 2026 Oct 19, 2026 Oct 18, 2026 Oct 17, 2026 Oct 16, 2026 Oct 15, 2026 Oct 14, 2026 Oct 13, 2026 Oct 11, 2026 Oct 10, 2026 Oct 9, 2026 Oct 8, 2026 Oct 7, 2026 Oct 3, 2026 Oct 2, 2026 Oct 1, 2026 Sep 30, 2026 Sep 29, 2026 Sep 27, 2026 Sep 26, 2026 Sep 25, 2026 Sep 24, 2026 Sep 23, 2026 Sep 19, 2026 Sep 18, 2026 Sep 17, 2026 Sep 16, 2026 Sep 14, 2026 Sep 13, 2026 Sep 12, 2026 Sep 11, 2026 Sep 10, 2026 Sep 9, 2026 Sep 8, 2026 Sep 5, 2026 Sep 4, 2026 Sep 3, 2026 Sep 2, 2026 Sep 1, 2026 Aug 31, 2026 Aug 30, 2026 Aug 29, 2026 Aug 28, 2026 Aug 27, 2026 Aug 26, 2026 Aug 25, 2026 Aug 23, 2026 Aug 22, 2026 Aug 21, 2026 Aug 20, 2026 Aug 19, 2026 Aug 18, 2026 Aug 17, 2026 Aug 16, 2026 Aug 15, 2026 Aug 14, 2026 Aug 13, 2026 Aug 12, 2026 Aug 11, 2026 Aug 10, 2026 Aug 9, 2026 Aug 8, 2026 Aug 7, 2026 Aug 6, 2026 Aug 5, 2026 Aug 4, 2026 Aug 3, 2026 Aug 2, 2026 Aug 1, 2026 Jul 31, 2026 Jul 30, 2026 Jul 29, 2026 Jul 28, 2026 Jul 27, 2026 Jul 26, 2026 Jul 25, 2026 Jul 24, 2026 Jul 23, 2026 Jul 22, 2026 Jul 21, 2026 Jul 20, 2026 Jul 19, 2026 Jul 18, 2026 Jul 17, 2026 Jul 16, 2026 Jul 12, 2026 Jul 11, 2026 Jul 10, 2026 Jul 9, 2026 Jul 3, 2026 Jul 2, 2026 Jul 1, 2026 Jun 30, 2026 Jun 28, 2026 Jun 27, 2026 Jun 26, 2026 Jun 25, 2026 Jun 24, 2026 Jun 20, 2026 Jun 19, 2026 Jun 18, 2026 Jun 17, 2026 Jun 15, 2026 Jun 14, 2026 Jun 13, 2026 Jun 12, 2026 Jun 11, 2026 Jun 10, 2026 Jun 9, 2026 Jun 6, 2026 Jun 5, 2026 Jun 4, 2026 Jun 3, 2026 Jun 2, 2026 Jun 1, 2026 May 31, 2026 May 30, 2026 May 29, 2026 May 28, 2026 May 27, 2026 May 26, 2026 May 24, 2026 May 23, 2026 May 22, 2026 May 21, 2026 May 20, 2026 May 19, 2026 May 18, 2026 May 17, 2026 May 16, 2026 May 15, 2026 May 14, 2026 May 13, 2026 May 12, 2026 May 11, 2026 May 10, 2026 May 9, 2026 May 8, 2026 May 7, 2026 May 6, 2026 May 5, 2026 May 4, 2026 May 3, 2026 May 2, 2026 May 1, 2026 Apr 30, 2026 Apr 29, 2026 Apr 23, 2026 Apr 22, 2026 Apr 21, 2026 Apr 20, 2026 Apr 18, 2026 Apr 17, 2026 Apr 16, 2026 Apr 15, 2026 Apr 14, 2026 Apr 13, 2026 Apr 10, 2026 Apr 9, 2026 Apr 8, 2026 Apr 7, 2026 Apr 2, 2026 Apr 1, 2026 Mar 31, 2026 Mar 30, 2026 Mar 26, 2026 Mar 25, 2026 Mar 20, 2026 Mar 19, 2026 Mar 18, 2026 Mar 17, 2026 Mar 16, 2026 Mar 13, 2026 Mar 12, 2026 Mar 11, 2026 Mar 9, 2026 Mar 7, 2026 Mar 6, 2026 Mar 5, 2026 Mar 4, 2026 Mar 3, 2026
135 companies Today

American Bitcoin Corp

ABTC Q3 2026
Reported: 2026-11-06

American Bitcoin fell 14.9% after earnings, as lower Bitcoin production and revenue, higher energy costs, and a drop in gross margin pointed to weaker mining economics. Net income and adjusted EBITDA were boosted by noncash gains from Bitcoin appreciation, which may have obscured the underlying operating deterioration.

Key takeaways
  • Mined approximately 891 Bitcoin, down from 932 in Q2; revenue declined about 5% to $63.4 million.
  • Gross profit fell to $25.8 million from $33 million, with gross margin down to 41% from 49%. Cost to mine rose to about $42,100 per Bitcoin from $36,500, primarily due to higher seasonal power costs.
  • Net income was approximately $126 million and adjusted EBITDA was $220.8 million, including $197.3 million in noncash digital-asset gains; the company said Bitcoin appreciated 39% during the quarter.
  • The reserve reached 8,427 Bitcoin at September 30, and Bitcoin per share increased 5% to approximately 11,600 satoshis per share. The company said it made no open-market Bitcoin purchases and issued no shares through its ATM program during the quarter.

ACADIA Pharmaceuticals Inc.

ACAD Q3 2026
Reported: 2026-11-06

Acadia reported higher third-quarter revenue and raised DAYBUE guidance, while its Phase II RADIANT study narrowly missed statistical significance on the primary endpoint. Shares fell 1.1% after earnings, a roughly flat reaction.

Key takeaways
  • Total revenue was $342 million, up 22% year over year on an adjusted basis.
  • DAYBUE sales reached a record $140 million, up 39%; management raised 2026 DAYBUE guidance.
  • NUPLAZID sales were $202 million, up 12% on an adjusted basis, with growth driven largely by patient demand through volume.
  • RADIANT’s Phase II portion narrowly missed statistical significance on its primary endpoint; Acadia plans to focus the Phase III program on the 60-milligram dose.
  • Acadia expects ILLUMERA Phase II results in LBD psychosis in the fourth quarter of 2027, while an additional NORLIGHT readout is now expected in the second half of 2027.

Axcelis Technologies, Inc.

ACLS Q3 2026
Reported: 2026-11-06

Shares fell 2.3%, a roughly flat reaction. Axcelis reported higher revenue and EPS than its own expectations, but lower gross margins from foreign-exchange headwinds tempered the result; the call also pointed to a mix of sequentially declining systems segments even as bookings improved.

Key takeaways
  • Q3 revenue was $238 million and diluted EPS was $1.26; management said both exceeded its expectations, helped by higher revenue and lower operating expenses.
  • Gross margins were lower due to foreign-exchange headwinds.
  • Systems revenue improved sequentially, while CS&I set another quarterly revenue record. Systems bookings grew significantly quarter over quarter, with a 1.5 book-to-bill ratio.
  • Silicon carbide sales grew notably sequentially, while general mature sales declined modestly and other power markets also dipped from a strong Q2.
  • Mature-node applications accounted for about 78% of system shipments; memory and advanced logic made up the balance.

Community

See what investors are trading, holding, and sharing

🌐
All
📈
Stock
📊
ETF
🏦
Mutual Fund
🪙
Crypto
💱
Forex
# Asset Price Community % Type Currency Sector
Loading...